Deutsch English Français

Contact

EP1687275

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1687275

EP1687275 - PYRIDIN-4-YLAMINE COMPOUNDS USEFUL IN THE TREATMENT OF NEUROPATHIC PAIN [Right-click to bookmark this link]
Status	The application has been withdrawn Status updated on 03.04.2009 Database last updated on 11.09.2024
Most recent event Tooltip	03.04.2009	Withdrawal of application	published on 06.05.2009 [2009/19]
Applicant(s)	For all designated states Merck & Co., Inc. 126 East Lincoln Avenue Rahway, New Jersey 07065-0907 / US
	[N/P]
Former [2006/32]	For all designated states Merck & Co., Inc. 126 East Lincoln Avenue Rahway New Jersey 07065-0907 / US
Inventor(s)	01 / LIM, Jongwon 126 East Lincoln Avenue Rahway, New Jersey 07065-0907 / US
	02 / BOUERES, Julia, K. 126 East Lincoln Avenue Rahway, New Jersey 07065-0907 / US
	03 / MUNOZ, Benito 126 East Lincoln Avenue Rahway, New Jersey 07065-0907 / US
	04 / PRACITTO, Richard 126 East Lincoln Avenue Rahway, New Jersey 07065-0907 / US
	05 / STOCK, Nicholas 126 East Lincoln Avenue Rahway, New Jersey 07065-0907 / US
	06 / VENKATRAMAN, Shankar 126 East Lincoln Avenue Rahway, New Jersey 07065-0907 / US
	[2006/32]
Representative(s)	Man, Jocelyn, et al Merck & Co., Inc. European Patent Department Merck Sharp & Dohme Limited Hertford Road, Hoddesdon Hertfordshire, EN11 9BU / GB
	[N/P]
Former [2006/48]	Man, Jocelyn, et al Merck & Co., Inc. European Patent Department Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon Hertfordshire, EN11 9BU / GB
Former [2006/32]	Man, Jocelyn, et al Merck & Co.,Inc. European Patent Department Terlings Park Eastwick Road Harlow, Essex CM20 2QR / GB
Application number, filing date	04811391.4	18.11.2004
	[2006/32]
	WO2004US38669
Priority number, date	US20030524734P	21.11.2003 Original published format: US 524734 P
	[2006/32]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2005051915
	Date:	09.06.2005
	Language:	EN
	[2005/23]
	Type:	A1 Application with search report
	No.:	EP1687275
	Date:	09.08.2006
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 09.06.2005 takes the place of the publication of the European patent application.
	[2006/32]
Search report(s)	International search report - published on:	US	09.06.2005
	(Supplementary) European search report - dispatched on:	EP	15.12.2008
Classification	IPC:	C07D215/00, C07D219/00, A61K31/435, A61K31/47, A61P25/00	[2009/03]
	CPC:	C07D219/12 (EP,US); A61P25/00 (EP); A61P25/04 (EP); A61P25/08 (EP); A61P25/14 (EP); A61P25/16 (EP); (+) A61P25/18 (EP); A61P25/20 (EP); A61P25/22 (EP); A61P25/24 (EP); A61P25/28 (EP); A61P25/34 (EP); A61P25/36 (EP); A61P29/00 (EP); A61P43/00 (EP); C07D215/46 (EP,US) (-)
	Former IPC [2006/32]	C07D215/00, C07D219/00, A61K31/435, A61K31/47
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/32]
Extension states	AL	Not yet paid
	HR	Not yet paid
	LT	21.06.2006
	LV	21.06.2006
	MK	Not yet paid
	YU	Not yet paid
Title	German:	ZUR BEHANDLUNG VON NEUROPATHISCHEN SCHMERZEN GEEIGNETE PYRIDIN-4-YLAMINVERBINDUNGEN	[2006/32]
	English:	PYRIDIN-4-YLAMINE COMPOUNDS USEFUL IN THE TREATMENT OF NEUROPATHIC PAIN	[2006/32]
	French:	COMPOSES DE PYRIDIN-4-YLAMINE CONVENANT POUR LE TRAITEMENT DE LA DOULEUR NEUROPATHIQUE	[2006/32]
Entry into regional phase	21.06.2006	National basic fee paid
	21.06.2006	Search fee paid
	21.06.2006	Designation fee(s) paid
	21.06.2006	Examination fee paid
Examination procedure	18.05.2006	Amendment by applicant (claims and/or description)
	21.06.2006	Examination requested [2006/32]
	27.03.2009	Application withdrawn by applicant [2009/19]
Fees paid	Renewal fee
	06.11.2006	Renewal fee patent year 03
	06.11.2007	Renewal fee patent year 04
	27.03.2008	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]US2077249 (FRITZ MIETZSCH, et al) [X] 1-9 * column W *;
		[X]EP0446604 (AMERICAN CYANAMID CO [US]) [X] 1-9 * example 116; claim - *;
		[X]WO9639818 (CERUS CORP [US], et al) [X] 1-9 * example 17; claim 11; table 23 *;
		[X]WO9721681 (MAYO FOUNDATION [US], et al) [X] 1-9 * figure 1; claim - *;
		[X]WO0032175 (PFIZER PROD INC [US]) [X] 1-9 * page 20 - page 21; claims 1,24 *;
		[X]WO0117529 (UNITECH PHARMACEUTICALS INC [US]) [X] 1-9 * page 1 - page 5; figure 1; claim - *;
		[X] - RA J S ET AL, "SYNTHESIS, PHARMACOLOGICAL ACTIVITIES & PHYSICO-CHEMICAL PROPERTIESOF 4-(SUBSTITUTED AMINO/N4-ARYLPIPERAZINYL/AMINOCARBONYL)-2,3- POLYMETHYLENEQUINOLINES", AN JOURNAL OF CHEMISTRY, JODHPUR, IN, (19870401), vol. 26B, no. 4, pages 318 - 329, XP000560899 [X] 1-5,9-11 * table 1 *
		[X] - STEINBERG G M ET AL, "A HYDROPHOBIC BINDING SITE IN ACETYLCHOLINESTERASE", JOURNAL OF MEDICINAL CHEMISTRY, US AMERICAN CHEMICAL SOCIETY. WASHINGTON, (19751101), vol. 18, no. 1, ISSN 0022-2623, pages 1056 - 1061, XP000651125 [X] 1-5,9,11 * page 1056 - page 1058; compound 11 * DOI: http://dx.doi.org/10.1021/jm00245a002
		[X] - APELT J ET AL, "Development of a new class of nonimidazole histamine H(3) receptor ligands with combined inhibitory histamine N-methyltransferase activity", JOURNAL OF MEDICINAL CHEMISTRY, US AMERICAN CHEMICAL SOCIETY. WASHINGTON, (20020228), vol. 45, no. 5, ISSN 0022-2623, pages 1128 - 1141, XP002280989 [X] 1-12 * page 1128 - page 1137 * DOI: http://dx.doi.org/10.1021/jm0110845
		[X] - WOYNAROWSKI J M ET AL, "INDUCTION OF DNA-PROTEIN CROSSLINKS BY ANTITUMOR 1-NITRO-9AMINOACRIDINES IN L1210 LEUKEMIA CELLS", BIOCHEMICAL PHARMACOLOGY, PERGAMON, OXFORD, GB, (19890901), vol. 38, no. 22, ISSN 0006-2952, pages 4095 - 4101, XP001094428 [X] 1-5,11 * page 4095; figure 1 * DOI: http://dx.doi.org/10.1016/0006-2952(89)90691-6
		[X] - C. HELLER, "prevention of the emergence of drug resistance in bacteria by acridines", APPLIED MICROBIOLOGY, usa, (1966), vol. 14, no. 6, pages 879 - 885, XP002506805 [X] 1-5,11 * page 879 - page 882 *
		[X] - E. SHEPARD, "nuclear substituted 9-(4'diethylamino-1'-methylbutylamino)-acridines.", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY., USAMERICAN CHEMICAL SOCIETY, WASHINGTON, DC., (1948), vol. 70, no. 5, pages 1979 - 1980, XP002506806 [X] 1-5,11 * page 1979 - page 1980 *
		[X] - L. SARGENT ET AL., "attempts to find new antimalarials.XIV.studies in the acridine series II.dialkylaminoalkylamines dervied from 9-chloro-1,2,3,4-tetrahydroacridine.", JOURNAL OF ORGANIC CHEMISTRY., USAMERICAN CHEMICAL SOCIETY. EASTON., (1946), vol. 11, no. 4, pages 359 - 362, XP002506807 [X] 1-9,11 * page 359 - page 362 * DOI: http://dx.doi.org/10.1021/jo01174a009
	International search	[X]US3066141 (JONES JR RALPH, et al);
		[X]US5021426 (BALDWIN JOHN J [US], et al);
		[X]EP0512890 (RHONE POULENC CHIMIE [FR])
		[X] - LAWS G.M., "mutation research", (2001), vol. 484, pages 3 - 18

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p